Skip to main content
. 2010 Nov 5;8:127. doi: 10.1186/1477-7525-8-127

Table 4.

Validation sample: Exploratory factor analysis solution (oblimin rotation)

Factors

DermaSat GS UE MC CU ID TE
Treatment effectiveness (TE)
 - Relief of symptoms -.054 -.021 -.036 -.032 -.032 .968
 - Feel better .166 .017 .045 .073 .237 .602
 - Disease under control .313 -.006 -.129 .105 .079 .504
Convenience of use (CU)
 - Ease of medication use .047 -.055 -.010 .860 .012 -.097
 - Convenient schedule -.077 .021 -.030 .877 -.016 .079
Impact on activities/daily living (ID)
 - Leisure activities .040 .085 .046 .104 .876 .011
 - Everyday activities -.105 -.106 -.073 -.094 .897 .068
 - Better mood .133 -.017 -.059 .019 .795 -.035
Medical care (MC)
 - Disease information -.015 .033 -.923 .031 .018 .022
 - Treatment information .032 -.014 -.917 -.040 .084 -.052
 - Treatment effects information .020 -.011 -.912 .048 -.070 .044
Undesirable side-effects (UE)
 - Impact on job activities .048 .940 .067 .044 -.040 .015
 - Impact on leisure activities -.069 .938 -.062 -.020 .072 -.015
 - Impact on activities of daily living .019 .923 -.013 -.055 -.039 -.001
General satisfaction (GS)
 - At ease with treatment .630 -.056 .073 .115 .203 .197
 - Better existing choice .927 .008 -.118 -.040 -.039 -.050
 - Satisfied with treatment .518 -.018 -.083 .026 .223 .281

Eigenvalues 7.17 2.65 1.75 1.27 0.69 0.61
Percentage of variance explained (%) 42.20 15.60 10.31 7.44 4.05 3.61

Factor correlation matrix

Undesirable side-effects (UE) -.049
Medical care (MC) -.460 .044
Convenience of use (CU) .272 -.193 -.233
Impact on activities/daily living (ID) .547 -.214 -.359 .259
Treatment effectiveness (TE) .483 -.121 -.288 .233 .605

Note: item labels have been shortened to fit the table.